These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1451 related articles for article (PubMed ID: 33081731)
21. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma. Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma. Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094 [TBL] [Abstract][Full Text] [Related]
23. Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma. Yang J; Jiang Q; Liu L; Peng H; Wang Y; Li S; Tang Y; Yu J; Gan R; Liu Z Aging (Albany NY); 2020 Nov; 12(24):25778-25804. PubMed ID: 33232279 [TBL] [Abstract][Full Text] [Related]
24. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
25. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
26. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma. Wang J; Chen X; Tian Y; Zhu G; Qin Y; Chen X; Pi L; Wei M; Liu G; Li Z; Chen C; Lv Y; Cai G Aging (Albany NY); 2020 Jan; 12(1):767-783. PubMed ID: 31927533 [TBL] [Abstract][Full Text] [Related]
27. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
28. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas. Ma B; Li H; Qiao J; Meng T; Yu R Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959 [TBL] [Abstract][Full Text] [Related]
29. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma. Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755 [TBL] [Abstract][Full Text] [Related]
30. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma. Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378 [TBL] [Abstract][Full Text] [Related]
31. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma. Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115 [TBL] [Abstract][Full Text] [Related]
32. Ubiquitination-Related Gene Signature, Nomogram and Immune Features for Prognostic Prediction in Patients with Head and Neck Squamous Cell Carcinoma. Yang H; Zhou L; Shi M; Yu J; Xie Y; Sun Y Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062659 [TBL] [Abstract][Full Text] [Related]
33. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392 [TBL] [Abstract][Full Text] [Related]
34. Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma. He J; Fang X; Han M Front Genet; 2021; 12():654657. PubMed ID: 34108990 [TBL] [Abstract][Full Text] [Related]
35. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma. Zhao X; Cui L J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519 [TBL] [Abstract][Full Text] [Related]
36. Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma. Liu S; Tian W; Li B J Comput Biol; 2020 Jan; 27(1):100-108. PubMed ID: 31460782 [TBL] [Abstract][Full Text] [Related]
37. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma. Chen L; Cai Z; Lyu K; Cai Z; Lei W Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440 [TBL] [Abstract][Full Text] [Related]
39. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma. Yang J; Xie K; Li C Life Sci; 2020 Sep; 256():117906. PubMed ID: 32504750 [TBL] [Abstract][Full Text] [Related]
40. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation. Zhong Q; Zhou L; Zhu D J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]